March 03, 2015 8:46 AM ET

Pharmaceuticals

Company Overview of Ansun Biopharma, Inc.

Executive Profile

Andrew Pavia M.D.

Chairman of Clinical Advisory Board, Ansun Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Andrew Pavia, M.D. serves as Chief for the Division of Pediatric Infectious Diseases at University of Utah School of Medicine. Dr. Pavia is the George and Esther Gross Presidential Professor. Dr. Pavia has been Chairman of Clinical Advisory Board of Ansun Biopharma, Inc. since April 2009. He serves as a Member of the Advisory Board at Body Health Resources Corporation. He leads several committees of the Infectious Diseases Society of America and has been a member ...

Corporate Headquarters

10665 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-452-2631
Fax: 858-452-2534

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
Brown University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ansun Biopharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.